BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27742823)

  • 1. The variable target model: a paradigm shift in the incremental haemodialysis prescription.
    Casino FG; Basile C
    Nephrol Dial Transplant; 2017 Jan; 32(1):182-190. PubMed ID: 27742823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing the dialysis dose and treatment frequency in home haemodialysis.
    Casino FG; Roblero MFS; González-Sanchidrian S; Dominguez SG; Ferris IL; Luyckx VA; Liakopoulos V; Mitra S; Lorenzo JD; Basile C
    Nephrol Dial Transplant; 2024 Feb; 39(3):445-452. PubMed ID: 37757455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.
    Daugirdas JT; Depner TA; Greene T; Kuhlmann MK; Levin NW; Chertow GM; Rocco MV
    Semin Dial; 2008; 21(5):415-21. PubMed ID: 18945330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose of dialysis based on body surface area is markedly less in younger children than in older adolescents.
    Daugirdas JT; Hanna MG; Becker-Cohen R; Langman CB
    Clin J Am Soc Nephrol; 2010 May; 5(5):821-7. PubMed ID: 20299373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent peritoneal dialysis: urea kinetic modeling and implications of residual kidney function.
    Guest S; Akonur A; Ghaffari A; Sloand J; Leypoldt JK
    Perit Dial Int; 2012; 32(2):142-8. PubMed ID: 22135316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality.
    Ramirez SP; Kapke A; Port FK; Wolfe RA; Saran R; Pearson J; Hirth RA; Messana JM; Daugirdas JT
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):1977-87. PubMed ID: 22977208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of standard Kt/V and surface area-normalized standard Kt/V with clinical outcomes in hemodialysis patients.
    Pattharanitima P; Chauhan K; El Shamy O; Chaudhary K; Sharma S; Coca SG; Nadkarni GN; Uribarri J; Chan L
    Hemodial Int; 2020 Oct; 24(4):495-505. PubMed ID: 32809268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial.
    Murea M; Moossavi S; Fletcher AJ; Jones DN; Sheikh HI; Russell G; Kalantar-Zadeh K
    BMJ Open; 2021 May; 11(5):e047596. PubMed ID: 34031117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.
    Kalantar-Zadeh K; Unruh M; Zager PG; Kovesdy CP; Bargman JM; Chen J; Sankarasubbaiyan S; Shah G; Golper T; Sherman RA; Goldfarb DS
    Am J Kidney Dis; 2014 Aug; 64(2):181-6. PubMed ID: 24840669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can rescaling dose of dialysis to body surface area in the HEMO study explain the different responses to dose in women versus men?
    Daugirdas JT; Greene T; Chertow GM; Depner TA
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1628-36. PubMed ID: 20595687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized hemodialysis: Is similar hemodialysis adequacy possible using less water?
    Aktaş A; Özer H; Baloğlu İ; Tonbul HZ; Güney İ; Selçuk NY
    Turk J Med Sci; 2023; 53(6):1863-1869. PubMed ID: 38813487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of formulas calculating normalized protein catabolic rate in patients undergoing home hemodialysis.
    Casino FG; Deira J; Roblero MFS; González-Sanchidrian S; Dominguez SG; Bilbao IC; de la Vega CG; Aguilar J; Rocha A; Basile C
    J Nephrol; 2023 Sep; 36(7):1965-1974. PubMed ID: 37341963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?
    Mathew AT; Obi Y; Rhee CM; Chou JA; Kalantar-Zadeh K
    Semin Dial; 2018 Jul; 31(4):343-352. PubMed ID: 29737013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Incremental 2-Times Weekly Hemodialysis in Incident Patients With Residual Kidney Function.
    Chin AI; Appasamy S; Carey RJ; Madan N
    Kidney Int Rep; 2017 Sep; 2(5):933-942. PubMed ID: 29270499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical approach to implementing incremental haemodialysis.
    Butt U; Davenport A; Sridharan S; Farrington K; Vilar E
    J Nephrol; 2024 May; ():. PubMed ID: 38763995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis.
    Takkavatakarn K; Jintanapramote K; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    Clin Kidney J; 2024 Jan; 17(1):sfad280. PubMed ID: 38186889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Dialysis Adequacy Using Small Solute Clearance Indices among Twice versus Thrice Weekly Maintenance Hemodialysis Patients in a Tertiary Care Hospital of Bangladesh.
    Khan SR; Roy AS; Hoque MR; Das SK; Hossain MB; Miah MOF; Nira NH; Salahuddin AZM; Islam H; Datta P
    Mymensingh Med J; 2024 Jan; 33(1):80-90. PubMed ID: 38163777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of hemodialysis after acute kidney injury in rats.
    Mallet J; Billiet PA; Scarton M; Benichou N; Bobot M; Chaibi K; Hertig A; Hadchouel J; Dreyfuss D; Gaudry S; Placier S
    Intensive Care Med Exp; 2023 Dec; 11(1):97. PubMed ID: 38117344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adequacy of haemodialysis and associated factors among patients with end-stage kidney disease in Tanzania.
    Bakari AI; Yahaya JJ; Matobogolo BM; Abraham ZS; Mpondo B
    J Taibah Univ Med Sci; 2024 Apr; 19(2):287-295. PubMed ID: 38283378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalising haemodialysis treatment with incremental dialysis for incident patients with end-stage kidney disease: an implementation study protocol.
    Armstrong M; Wityk Martin TL; Zimmermann GL; Drall K; Pannu NI
    BMJ Open; 2024 Jan; 14(1):e075195. PubMed ID: 38286687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.